Similar Search Results

Innovationssysteme in einem finanzdominierten Akkumulationsregime : Befunde und Thesen

Zeller, Christian - In: Geographische Zeitschrift : GZ 91 (2003) 3/4, pp. 133-155

Persistent link: https://www.econbiz.de/10002559260

Signaling by early stage startups : US government research grants and venture capital funding

Islam, Mazhar; Fremeth, Adam; Marcus, Alfred A. - In: Journal of business venturing 33 (2018) 1, pp. 35-51

Persistent link: https://www.econbiz.de/10011792508

Monetary Policy and Innovation

Ma, Yueran; Zimmermann, Kaspar - National Bureau of Economic Research - 2023

declines by about 25 percent in the following 1 to 3 years. Patenting in important technologies, as well as a patent …

Persistent link: https://www.econbiz.de/10014372455

Patents in the university : priming the pump and crowding out

Scotchmer, Suzanne - 2013

Persistent link: https://www.econbiz.de/10009784740

Public R&D investments and private-sector patenting : evidence from NIH funding rules

Azoulay, Pierre; Zivin, Joshua S. Graff; Li, Danielle; … - 2015

Persistent link: https://www.econbiz.de/10010490192

Financing innovation : evidence from R&D grants

Howell, Sabrina T. - In: The American economic review 107 (2017) 4, pp. 1136-1164

Persistent link: https://www.econbiz.de/10011644959

Collaboration or funding : lessons from a study of nanotechnology patenting in Canada and the United States

Tahmooresnejad, Leila; Beaudry, Catherine - In: The journal of technology transfer 44 (2019) 3, pp. 741-777

Persistent link: https://www.econbiz.de/10012053160

Simultaneous pursuit of discovery and invention in the US Department of Energy

Goldstein, Anna P.; Narayanamurti, Venkatesh - In: Research policy : policy, management and economic … 47 (2018) 8, pp. 1505-1512

Persistent link: https://www.econbiz.de/10011975791

The Feasibility of Using Bayh-Dole March-In Rights to Lower Drug Prices : An Update

Ouellette, Lisa Larrimore; Sampat, Bhaven N. - National Bureau of Economic Research - 2024

Administration (FDA) from 1985 to 2022. Our primary analyses focus on the 883 new molecular entities with at least one patent listed … in the FDA's Orange Book since 1985. While 9 percent of these drugs have a public-sector patent, only 2.5 percent have …

Persistent link: https://www.econbiz.de/10014512071

Estimating spillovers from publicly funded R&D : evidence from the US department of energy

Myers, Kyle R.; Lanahan, Lauren - In: American economic review 112 (2022) 7, pp. 2393-2423

Persistent link: https://www.econbiz.de/10013336043

1
2
3
4
5
6
7
8
9
10
Next
Last